Real-time enrollment status for this epidermolysis bullosa simplex clinical trial
Current Status
Active, Not Recruiting
Checked: June 2, 2026 at 1:11 AM UTC
| NCT Number | NCT06073132 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Epidermolysis Bullosa Simplex |
| Phase | Clinical Trial |
| Target Enrollment | 80 participants |
| Active Locations | 9 sites in the US |
| Sponsor | TWi Biotechnology, Inc. |
| Last Updated on CT.gov | April 24, 2026 (Apr 24, 2026) |
As of June 2, 2026: Clinical trial NCT06073132 is currently active_not_recruiting participants. This clinical trial study for epidermolysis bullosa simplex is not currently accepting new participants at 9 locations across the United States. The study is sponsored by TWi Biotechnology, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06073132 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06073132 was last updated Apr 24, 2026 (April 24, 2026). HelloStudys verifies this status automatically.